Reference
Scottish Medicines Consortium. SMC advice: azelastine hydrochloride plus fluticasone propionate (Dymista); eltrombopag (Revolade); mannitol (Bronchitol); saxagliptin (Onglyza); vemurafenib (Zelboraf); vildagliptin (Galvus). Internet Document : 9 Dec 2013. Available from: URL: http://www.scottishmedicines.org.uk
Rights and permissions
About this article
Cite this article
SMC publishes December 2013 decisions. PharmacoEcon Outcomes News 694, 11 (2014). https://doi.org/10.1007/s40274-014-0987-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-0987-8